Cargando…

Comparison of the Phytochemical Composition of Serenoa repens Extracts by a Multiplexed Metabolomic Approach

Phytochemical extracts are highly complex chemical mixtures. In the context of an increasing demand for phytopharmaceuticals, assessment of the phytochemical equivalence of extraction procedures is of utmost importance. Compared to routine analytical methods, comprehensive metabolite profiling has p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marti, Guillaume, Joulia, Philippe, Amiel, Aurélien, Fabre, Bernard, David, Bruno, Fabre, Nicolas, Fiorini-Puybaret, Christel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631273/ https://www.ncbi.nlm.nih.gov/pubmed/31200456 http://dx.doi.org/10.3390/molecules24122208

Ejemplares similares

Is Serenoa repens Effective in the Treatment of Benign Prostatic Hyperplasia?
por: Çeker, Gökhan
Publicado: (2020)

Serenoa Repens: Does It have Any Role in the Management of Androgenetic Alopecia?
por: Murugusundram, Sundaram
Publicado: (2009)

A substitute variety for agronomically and medicinally important Serenoa repens (saw palmetto)
por: Jaiswal, Yogini, et al.
Publicado: (2019)

Hexanic Extract of Serenoa repens (Permixon(®)): A Review in Symptomatic Benign Prostatic Hyperplasia
por: Blair, Hannah A.
Publicado: (2022)

Lipidosterolic Extract of Serenoa Repens Modulates the Expression of Inflammation Related-Genes in Benign Prostatic Hyperplasia Epithelial and Stromal Cells
por: Sirab, Nanor, et al.
Publicado: (2013)

Inhibitors of apoptosis proteins in experimental benign prostatic hyperplasia: effects of serenoa repens, selenium and lycopene
por: Minutoli, Letteria, et al.
Publicado: (2014)

Correction to: Hexanic Extract of Serenoa repens (Permixon(®)): A Review in Symptomatic Benign Prostatic Hyperplasia
por: Blair, Hannah A.
Publicado: (2022)

The Role of Combination Therapy with α-Blockers and Hexanic Extract of Serenoa repens in the Treatment of LUTS/BPH
por: De Nunzio, Cosimo, et al.
Publicado: (2022)

Comparison of Serenoa repens With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis
por: Cai, Tong, et al.
Publicado: (2020)

Efficacy and tolerability of the hexanic extract of Serenoa repens compared to tamsulosin in moderate-severe LUTS-BPH patients
por: Alcaraz, Antonio, et al.
Publicado: (2021)

Modern extraction techniques and their impact on the pharmacological profile of Serenoa repens extracts for the treatment of lower urinary tract symptoms
por: De Monte, Celeste, et al.
Publicado: (2014)

Lipomatrix: A Novel Ascorbyl Palmitate-Based Lipid Matrix to Enhancing Enteric Absorption of Serenoa Repens Oil
por: Fratter, Andrea, et al.
Publicado: (2019)

Serenoa repens and Urtica dioica Fixed Combination: In-Vitro Validation of a Therapy for Benign Prostatic Hyperplasia (BPH)
por: Saponaro, Miriam, et al.
Publicado: (2020)

Effect of Serenoa repens (Permixon®) on the expression of inflammation-related genes: analysis in primary cell cultures of human prostate carcinoma
por: Silvestri, Ida, et al.
Publicado: (2013)

Observational study: daily treatment with a new compound “tradamixina” plus serenoa repens for two months improved the lower urinary tract symptoms
por: Iacono, Fabrizio, et al.
Publicado: (2012)

Clinically Meaningful Improvements in LUTS/BPH Severity in Men Treated with Silodosin Plus Hexanic Extract of Serenoa Repens or Silodosin Alone
por: Boeri, Luca, et al.
Publicado: (2017)

Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement: A systematic review and meta-analysis
por: Trivisonno, Leonel Fabrizio, et al.
Publicado: (2021)

Survivin and NAIP in Human Benign Prostatic Hyperplasia: Protective Role of the Association of Serenoa repens, Lycopene and Selenium from the Randomized Clinical Study
por: Morgia, Giuseppe, et al.
Publicado: (2017)

The Clinical Impact of Hexanic Extract of Serenoa repens in Men with Prostatic Inflammation: A Post Hoc Analysis of a Randomized Biopsy Study
por: Samarinas, Michael, et al.
Publicado: (2020)

Retraction Note: Observational study: daily treatment with a new compound “tradamixina” plus serenoa repens for two months improved the lower urinary tract symptoms
por: Iacono, Fabrizio, et al.
Publicado: (2016)

Effects of hexanic extract of serenoa repens (permixon(®) 160 mg) on inflammation biomarkers in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia
por: Latil, Alain, et al.
Publicado: (2015)

Clinical Benefit of Tamsulosin and the Hexanic Extract of Serenoa Repens, in Combination or as Monotherapy, in Patients with Moderate/Severe LUTS-BPH: A Subset Analysis of the QUALIPROST Study
por: Alcaraz, Antonio, et al.
Publicado: (2020)

Hypothesis on Serenoa repens (Bartram) small extract inhibition of prostatic 5α-reductase through an in silico approach on 5β-reductase x-ray structure
por: Governa, Paolo, et al.
Publicado: (2016)

Efficacy and Safety of the Hexanic Extract of Serenoa repens vs. Watchful Waiting in Men with Moderate to Severe LUTS-BPH: Results of a Paired Matched Clinical Study
por: Alcaraz, Antonio, et al.
Publicado: (2022)

The efficacy and safety of Serenoa repens extract for the treatment of patients with chronic prostatitis/chronic pelvic pain syndrome: a multicenter, randomized, double-blind, placebo-controlled trial
por: Zhang, Kai, et al.
Publicado: (2021)

Flower Pollen Extract in Association with Vitamins (Deprox 500(®)) Versus Serenoa repens in Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Comparative Analysis of Two Different Treatments
por: Macchione, Nicola, et al.
Publicado: (2019)

Development of a multiplex qPCR-based approach for the diagnosis of Dirofilaria immitis, D. repens and Acanthocheilonema reconditum
por: Laidoudi, Younes, et al.
Publicado: (2020)

Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study
por: Alcaraz, Antonio, et al.
Publicado: (2022)

Autochthonous Dirofilaria repens in Austria
por: Silbermayr, Katja, et al.
Publicado: (2014)

A Case of Dermatitis Repens
por: Nicol, J. Wyllie
Publicado: (1909)

Dirofilaria repens infection of the eye
por: Engelsberg, Karl, et al.
Publicado: (2022)

Vaccinium Crassifolium Aut Repens
Publicado: (1880)

Inhibitory Potential of Acroptilon repens against Key Enzymes involved in Alzheimer and Diabetes, Phytochemical Profile, Radical Scavenging, and Antibacterial Activity
por: Afsharnezhad, Moslem, et al.
Publicado: (2021)

Influence of Altitude on Phytochemical Composition of Hemp Inflorescence: A Metabolomic Approach
por: Giupponi, Luca, et al.
Publicado: (2020)

Dirofilaria repens Infection and Concomitant Meningoencephalitis
por: Poppert, Sven, et al.
Publicado: (2009)

Dirofilaria repens transmission in southeastern Finland
por: Pietikäinen, Risto, et al.
Publicado: (2017)

Dirofilaria repens in dogs and humans in Lithuania
por: Sabūnas, Vytautas, et al.
Publicado: (2019)

Dirofilaria Repens in Dogs and Humans in Slovenia
por: Kotnik, Tina, et al.
Publicado: (2022)

Escuela activa experimental
por: Fabre, Aurélien

Phytochemical identification, acute and subchronic oral toxicity assessments of hydroalcoholic extract of Acroptilon repens in BALB/c mice: A toxicological and mechanistic study
por: Dashti, Ayat, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p633tfbh7a0vgojt3c66fdtdgc